Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency-Reference-Cited by-同舟云学术

Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency

Published:2006-09 Issue:3 Volume:120 Page:310-318
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Alachkar Hana,Taubenheim Nadine,Haeney Mansel R.,Durandy Anne,Arkwright Peter D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference37 articles.

1. Primary immunodeficiency disorders: antibody deficiency;Ballow;J. Allergy Clin. Immunol.,2002

2. Primary hypogammaglobulinemia: a survey of clinical manifestations and complications;Hermaszewski;Q. J. Med.,1993

3. Common variable immunodeficiency: clinical and immunological features of 248 patients;Cunningham-Rundles;Clin. Immunol.,1992

4. Autoimmune disease in primary antibody deficiencies;Sarmiento;Allergol. Immunopathol.,2005

5. Tackling the heterogeneity of CVID;Goldacker;Curr. Opin. Allergy Clin. Immunol.,2005

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell phenotype, activity, and function in idiopathic nephrotic syndrome;Pediatric Research;2022-10-31

2. Novel mutation and expanding phenotype in IRF2BP2 deficiency;Rheumatology;2022-10-04

3. Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum Disorders;Neurology - Neuroimmunology Neuroinflammation;2022-07-19

4. Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update;Frontiers in Immunology;2022-06-20

5. Evaluation of Specific Antibody Responses in Patients with Selective IgA Deficiency and Ataxia Telangiectasia;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-05